Usporedite metode
Pregledajte odabrane metode jednu uz drugu; retci koji se razlikuju su istaknuti.
| Analiza troškova i koristi (CBA)× | Analiza troškovne učinkovitosti (CEA)× | |
|---|---|---|
| Područje | Zdravstvena ekonomija | Zdravstvena ekonomija |
| Obitelj | Process / pipeline | Process / pipeline |
| Godina nastanka≠ | 1970s | 1984 |
| Tvorac≠ | Boardman, Greenberg, and colleagues (welfare economics) | Drummond & Stoddart (Health Economics Research Group, McMaster University) |
| Vrsta | Method | Method |
| Temeljni izvor≠ | Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (2018). Cost-Benefit Analysis: Concepts and Practice (5th ed.). Cambridge: Cambridge University Press. link ↗ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press. link ↗ |
| Drugi nazivi | CBA, economic appraisal, benefit-cost ratio | CEA, ICER, Incremental Cost-Effectiveness Ratio |
| Srodne | 5 | 5 |
| Sažetak≠ | Cost-benefit analysis compares the total monetary value of benefits produced by a program against its total monetary costs, reporting net present value (NPV) or benefit-cost ratio (BCR). Rooted in welfare economics and used extensively in public policy (transportation, environmental, education, health), CBA answers the question: 'Is this program worth doing from a societal perspective?' Unlike cost-effectiveness analysis, CBA monetizes both costs and benefits, enabling comparison across disparate program types. | Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price. |
| ScholarGateSkup podataka ↗ |
|
|